Skip to main content
EU OKs bacterial panel from T2 Biosystems
7/19/2017

T2 Biosystems' T2Bacteria Panel has been granted CE mark approval by European regulators. The panel, which will be released in Europe in the third quarter as part of the company's T2Sepsis Solution, operates on the company's T2Dx instrument and takes about 3.5 hours to deliver species-specific results of targeted bacterial infections using whole blood.

Full Story: